The Chemours Company (CC) Key Metrics
CC valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $1.92B
- Enterprise value
- $5.70B
- P/E (TTM)
- — 10-yr median 12.8
- Forward P/E
- 7.3
- PEG ratio
- 1.60
- Price / sales
- 0.3 10-yr median 0.8
- Price / book
- 12.5 10-yr median 5.2
- EV / EBITDA
- 10.5 10-yr median 9.0
- Dividend yield
- 2.75% $0.35 a year
- Beta
- 1.40
CC key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCC valuation Price multiples at each fiscal year-end price.
CC returns How much profit the business earns on the capital it uses.
CC per-share figures Results divided by the shares outstanding at year-end.
CC financial health Debt, liquidity and how easily interest is covered.
CC efficiency & capital use Working capital cycle and where the cash goes.
CC valuation history
CC returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CC debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CC cash returned to shareholders
CC price vs earnings per share
CC key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $1.77B | $2.54B | $4.70B | $4.85B | $5.66B | $4.12B | $2.98B | $5.15B | $9.56B | $4.05B |
| Enterprise value | $5.69B | $6.18B | $7.79B | $7.63B | $8.20B | $7.30B | $6.51B | $7.92B | $12.12B | $6.69B |
| P/E ratio | — | 29.5 | — | 8.4 | 9.3 | 18.8 | — | 5.2 | 12.8 | 578.8 |
| Price / sales | 0.3 | 0.4 | 0.8 | 0.7 | 0.9 | 0.8 | 0.5 | 0.8 | 1.5 | 0.8 |
| Price / book | 7.1 | 4.2 | 6.4 | 4.4 | 5.2 | 5.1 | 4.3 | 5.1 | 11.1 | 40.5 |
| Price / free cash flow | 34.8 | — | 25.3 | 10.8 | 10.4 | 7.6 | 17.6 | 8.0 | 41.9 | 15.8 |
| Price / operating cash flow | 6.7 | — | 8.4 | 6.4 | 6.9 | 5.1 | 4.6 | 4.5 | 15.0 | 6.8 |
| EV / sales | 1.0 | 1.1 | 1.3 | 1.1 | 1.3 | 1.5 | 1.2 | 1.2 | 2.0 | 1.2 |
| EV / EBITDA | 17.1 | 8.9 | 39.6 | 6.4 | 7.0 | 9.5 | 8.6 | 5.1 | 9.0 | 9.4 |
| EV / free cash flow | 111.5 | — | 41.9 | 17.1 | 15.1 | 13.5 | 38.5 | 12.3 | 53.1 | 26.1 |
| Earnings yield | −21.7% | 3.4% | −5.1% | 11.9% | 10.7% | 5.3% | −1.7% | 19.3% | 7.8% | 0.2% |
| Free cash flow yield | 2.9% | −39.2% | 4.0% | 9.2% | 9.6% | 13.1% | 5.7% | 12.5% | 2.4% | 6.3% |
| Dividend yield | 4.4% | 5.8% | 3.2% | 3.2% | 2.9% | 4.0% | 5.5% | 2.9% | 0.2% | 0.5% |
| Shareholder yield (dividends + buybacks) | 4.5% | 6.0% | 4.6% | 13.4% | 6.0% | 4.0% | 16.3% | 15.4% | 1.3% | 0.5% |
| Share price at fiscal year-end | $11.79 | $16.90 | $31.54 | $30.62 | $33.56 | $24.79 | $18.09 | $28.22 | $50.06 | $22.09 |
| Per share | ||||||||||
| Revenue per share | $38.58 | $38.54 | $40.82 | $43.15 | $37.61 | $29.87 | $33.53 | $36.36 | $32.37 | $29.44 |
| Earnings per share | −$2.56 | $0.57 | −$1.60 | $3.65 | $3.60 | $1.32 | −$0.32 | $5.45 | $3.91 | $0.04 |
| Operating cash flow per share | $1.75 | −$4.22 | $3.73 | $4.76 | $4.86 | $4.85 | $3.94 | $6.24 | $3.35 | $3.24 |
| Free cash flow per share | $0.34 | −$6.62 | $1.25 | $2.82 | $3.22 | $3.25 | $1.03 | $3.52 | $1.19 | $1.40 |
| Cash per share | $4.46 | $4.75 | $8.08 | $6.96 | $8.60 | $6.64 | $5.72 | $6.58 | $8.15 | $4.92 |
| Book value per share | $1.66 | $4.03 | $4.95 | $6.99 | $6.41 | $4.89 | $4.18 | $5.55 | $4.50 | $0.55 |
| Tangible book value per share | $1.34 | $3.70 | $4.24 | $6.27 | $5.77 | $3.88 | $3.12 | $4.56 | $3.63 | −$0.38 |
| Dividends per share | $0.52 | $0.99 | $1.00 | $0.97 | $0.97 | $0.99 | $1.00 | $0.81 | $0.12 | $0.12 |
| Capex per share | $1.41 | $2.40 | $2.48 | $1.94 | $1.64 | $1.61 | $2.92 | $2.73 | $2.15 | $1.84 |
| Debt per share | $30.45 | $29.03 | $28.87 | $24.51 | $23.63 | $25.71 | $27.13 | $21.76 | $21.53 | $19.32 |
| Shares outstanding | 150.6M | 150.0M | 148.9M | 158.3M | 168.7M | 166.3M | 164.8M | 182.6M | 191.0M | 183.4M |
| Change in shares outstanding | +0.4% | +0.7% | −5.9% | −6.2% | +1.4% | +0.9% | −9.7% | −4.4% | +4.1% | +1.3% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −90.4% | 12.8% | −25.8% | 52.8% | 64.2% | 29.2% | −6.1% | 106.2% | 155.4% | 6.2% |
| Return on invested capital (ROIC) | −0.1% | 7.4% | −2.5% | 16.3% | 15.9% | 10.9% | 5.6% | 29.5% | 28.5% | 2.3% |
| Return on assets (ROA) | −5.2% | 1.1% | −3.0% | 7.6% | 8.3% | 3.1% | −0.7% | 13.6% | 11.2% | 0.1% |
| Return on tangible assets | −5.3% | 1.2% | −2.9% | 7.7% | 8.2% | 3.2% | −0.7% | 13.9% | 10.5% | 0.1% |
| Free cash flow margin | 0.9% | −17.2% | 3.1% | 6.5% | 8.6% | 10.9% | 3.1% | 9.7% | 3.7% | 4.7% |
| Income quality (OCF / net income) | — | −7.36 | — | 1.30 | 1.35 | 3.68 | — | 1.15 | 0.86 | 84.86 |
| Financial health | ||||||||||
| Total debt | $4.58B | $4.36B | $4.30B | $3.88B | $3.99B | $4.28B | $4.47B | $3.97B | $4.11B | $3.54B |
| Cash & short-term investments | $672.0M | $713.0M | $1.20B | $1.10B | $1.45B | $1.10B | $943.0M | $1.20B | $1.56B | $902.0M |
| Net debt | $3.91B | $3.64B | $3.10B | $2.78B | $2.54B | $3.17B | $3.53B | $2.77B | $2.56B | $2.64B |
| Debt / equity | 18.34 | 7.21 | 5.83 | 3.50 | 3.69 | 5.26 | 6.49 | 3.92 | 4.78 | 35.44 |
| Debt / assets | 0.62 | 0.58 | 0.52 | 0.51 | 0.53 | 0.60 | 0.62 | 0.54 | 0.56 | 0.58 |
| Net debt / EBITDA | 11.79 | 5.26 | 15.72 | 2.32 | 2.15 | 4.14 | 4.65 | 1.80 | 1.90 | 3.70 |
| Current ratio | 1.78 | 1.68 | 1.54 | 1.70 | 1.80 | 1.83 | 1.80 | 1.93 | 2.12 | 1.44 |
| Quick ratio | 0.85 | 0.86 | 1.00 | 0.96 | 1.21 | 1.17 | 1.10 | 1.26 | 1.55 | 1.01 |
| Interest coverage | -0.0 | 1.7 | -0.6 | 4.8 | 3.6 | 2.1 | 2.1 | 6.3 | 5.0 | 0.4 |
| Working capital | $1.31B | $1.22B | $1.35B | $1.32B | $1.49B | $1.19B | $1.24B | $1.58B | $1.84B | $782.0M |
| Invested capital | $4.16B | $4.25B | $3.83B | $3.88B | $3.62B | $3.98B | $4.22B | $3.79B | $3.42B | $2.74B |
| Tangible asset value | $203.0M | $556.0M | $634.0M | $992.0M | $974.0M | $648.0M | $521.0M | $839.0M | $699.0M | −$66.0M |
| Net current asset value | −$4.13B | −$3.88B | −$3.68B | −$3.32B | −$3.12B | −$3.63B | −$3.79B | −$3.05B | −$2.94B | −$3.40B |
| Graham number | — | $7.21 | — | $23.97 | $22.80 | $12.03 | — | $26.10 | $19.89 | $0.68 |
| Graham net-net per share | −$34.31 | −$32.55 | −$34.76 | −$26.91 | −$23.28 | −$25.91 | −$27.76 | −$21.48 | −$19.45 | −$22.16 |
| Capital allocation | ||||||||||
| Dividends paid | $78.0M | $148.0M | $149.0M | $154.0M | $164.0M | $164.0M | $164.0M | $148.0M | $22.0M | $22.0M |
| Share buybacks (net) | $1.0M | $3.0M | $69.0M | $495.0M | $173.0M | $0 | $322.0M | $644.0M | $106.0M | $0 |
| Dividend payout ratio | — | 172.1% | — | 26.6% | 27.0% | 74.9% | — | 14.9% | 2.9% | 314.3% |
| Dividends + buybacks / free cash flow | 154.9% | — | 117.2% | 145.2% | 62.1% | 30.4% | 287.6% | 123.4% | 56.1% | 8.6% |
| Capex / revenue | 3.7% | 6.2% | 6.1% | 4.5% | 4.4% | 5.4% | 8.7% | 7.5% | 6.6% | 6.3% |
| Capex / operating cash flow | 80.7% | — | 66.5% | 40.7% | 33.8% | 33.1% | 74.0% | 43.7% | 64.3% | 56.9% |
| Capex / depreciation | 0.63 | 1.20 | 1.21 | 1.05 | 0.87 | 0.83 | 1.55 | 1.75 | 1.51 | 1.19 |
| Stock-based compensation / revenue | 0.4% | 0.3% | 0.3% | 0.4% | 0.5% | 0.3% | 0.3% | 0.4% | 0.5% | 0.4% |
| R&D / revenue | 1.9% | 1.9% | 1.8% | 1.7% | 1.7% | 1.9% | 1.4% | 1.2% | 1.3% | 1.5% |
| SG&A / revenue | 13.8% | 10.1% | 21.2% | 10.4% | 9.3% | 10.6% | 9.9% | 9.9% | 9.7% | 17.3% |
| Efficiency | ||||||||||
| Days sales outstanding | 45.5 | 43.6 | 37.1 | 36.0 | 35.4 | 43.5 | 50.7 | 48.9 | 50.9 | 56.3 |
| Days of inventory on hand | 113.1 | 111.3 | 105.4 | 87.6 | 74.9 | 94.4 | 91.0 | 81.4 | 70.1 | 74.0 |
| Days payables outstanding | 76.2 | 88.8 | 89.6 | 82.3 | 72.1 | 80.5 | 83.3 | 86.5 | 80.7 | 77.8 |
| Cash conversion cycle (days) | 82.4 | 66.0 | 52.9 | 41.3 | 38.2 | 57.4 | 58.4 | 43.9 | 40.4 | 52.5 |
| Receivables turnover | 8.02 | 8.38 | 9.83 | 10.15 | 10.31 | 8.39 | 7.20 | 7.46 | 7.16 | 6.48 |
| Payables turnover | 4.79 | 4.11 | 4.07 | 4.44 | 5.06 | 4.53 | 4.38 | 4.22 | 4.52 | 4.69 |
| Inventory turnover | 3.23 | 3.28 | 3.46 | 4.17 | 4.87 | 3.87 | 4.01 | 4.48 | 5.20 | 4.93 |
| Asset turnover | 0.78 | 0.73 | 0.76 | 0.90 | 0.87 | 0.69 | 0.76 | 0.91 | 0.93 | 0.87 |
| Average receivables | $724.5M | $690.0M | $618.0M | $673.0M | $615.5M | $592.5M | $767.5M | $890.0M | $863.0M | $833.0M |
| Average payables | $1.02B | $1.13B | $1.17B | $1.18B | $980.5M | $860.5M | $1.02B | $1.11B | $979.5M | $914.5M |
| Average inventory | $1.52B | $1.41B | $1.38B | $1.25B | $1.02B | $1.01B | $1.11B | $1.04B | $851.0M | $869.5M |
| Intangibles / total assets | 0.7% | 0.7% | 1.3% | 1.5% | 1.4% | 2.4% | 2.4% | 2.5% | 2.3% | 2.8% |
Computed from CC's annual financial statements (latest annual report filed February 24, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CC valuation and financial ratios
Chemours earned a return on equity of −90.4% and a return on invested capital of −0.1% in fiscal 2025. It ended the year with $4.6 billion of debt and $672.0 million in cash and short-term investments, net debt of $3.9 billion. It returned $79.0 million to shareholders: $78.0 million in dividends and $1.0 million in share buybacks, 155% of free cash flow. The share count fell 17.9% from 183.4M to 150.6M over 9 years.
See the CC income statement, the CC chart for price history, or the CC stock overview for the latest quote and news.
CC key metrics FAQ
What is Chemours's EV/EBITDA?
Chemours's enterprise value was 17.1 times EBITDA at the end of fiscal 2025 (enterprise value $5.7 billion, EBITDA $332.0 million); the current EV/EBITDA is 10.5.
What is Chemours's return on equity?
Chemours's return on equity (ROE) was −90.4% in fiscal 2025: net income of -$386.0 million on average shareholders' equity of $427.0 million.
What is Chemours's ROIC?
Chemours's return on invested capital was −0.1% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Chemours have?
Chemours had total debt of $4.6 billion at the end of fiscal 2025, a debt-to-equity ratio of 18.34 and $3.9 billion of net debt (11.79 times EBITDA).
What is Chemours's dividend yield?
Chemours's forward dividend yield is 2.75%. Chemours paid $78.0 million in dividends in fiscal 2025 ($0.52 per share), a payout ratio of —.
Does Chemours buy back its shares?
Yes. Chemours spent $1.0 million on net share repurchases in fiscal 2025 Shares outstanding changed +0.4% over the year, to 150.6M..
What is Chemours's free cash flow yield?
Chemours generated $51.0 million of free cash flow in fiscal 2025, a free cash flow yield of 2.9% on its market value at year-end ($1.8 billion).
What is Chemours's current ratio?
Chemours's current ratio was 1.78 at the end of fiscal 2025: current assets were 1.78 times current liabilities.